CORT vs IT · P/E 199, rev $675.0M vs P/E 16, rev $6.27B
Corcept Therapeutics Incorporated (CORT) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the CORT and IT stock pages for the full models.
Not investment advice.